EBRO 2017
Survival better
• 8.9 vs. 11.6 months • Persists on multivariate analysis
• Single centre • In USA
• Other studies NOT shown OS benefit
Temel, NEJM, 2010
Made with FlippingBook Learn more on our blog
Survival better
• 8.9 vs. 11.6 months • Persists on multivariate analysis
• Single centre • In USA
• Other studies NOT shown OS benefit
Temel, NEJM, 2010
Made with FlippingBook Learn more on our blog